Plasminogen-related growth factor and semaphorin receptors: A gene superfamily controlling invasive growth

Experimental Cell Research

Volumn 253, Issue 1, 1999, Pages 88-99

  Comoglio, Paolo M ^a   Tamagnone, Luca ^a   Boccaccio, Carla ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

HGF; Met; MSP; Plexin; PRGF; Ron; Semaphorin

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; RECEPTOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SEMAPHORIN; SEMAPHORIN RECEPTOR; UNCLASSIFIED DRUG;

CANCER INVASION; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; DEREGULATION; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; METASTASIS; MORPHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033604556     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4684     Document Type: Article

References (131)

1. Tamagnone L., Comoglio P. M. Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. Cytokine Growth Factor Rev. 8:1997;129-142.
2. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA. 83:1986;6489-6493.
3. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
4. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81:1988;414-419.
5. Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 86:1989;5844-5848.
6. Zarnegar R., Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:1989;3314-3320.
7. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:1990;2097-2108.
8. Sonnenberg E., Meyer D., Weidner K. M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:1993;223-235.
9. Kobayashi T., Honke K., Miyazaki T., Matsumoto K., Nakamura T., Ishizuka I., Makita A. Hepatocyte growth factor specifically binds to sulfoglycolipids. J. Biol. Chem. 269:1994;9817-9821.
10. Lokker N. A., Mark M. R., Luis E. A., Bennett G. L., Robbins K. A., Baker J. B., Godowski P. J. Structure-function analysis of hepatocyte growth factor: Identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11:1992;2503-2510.
11. Mizuno K., Inoue H., Hagiya M., Shimizu S., Nose T., Shimohigashi Y., Nakamura T. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269:1994;1131-1136.
12. Hartmann G., Prospero T., Brinkmann V., Ozcelik O., Winter G., Hepple J., Batley S., Bladt F., Sachs M., Birchmeier C., Birchmeier W., Gherardi E. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8:1998;125-134.
13. Donate L. E., Gherardi E., Srinivasan N., Sowdhamini R., Aparicio S., Blundell T. L. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci. 3:1994;2378-2394.
14. Seki T., Hagiya M., Shimonishi M., Nakamura T., Shimizu S. Organization of the human hepatocyte growth factor-encoding gene. Gene. 102:1991;213-219.
15. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:1992;4825-4833.
16. Mars W. M., Zarnegar R., Michalopoulos G. K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143:1993;949-958.
17. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 268:1993;10024-10028.
18. Shimomura T., Miyazawa K., Komiyama Y., Hiraoka H., Naka D., Morimoto Y., Kitamura N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem. 229:1995;257-261.
19. Kawaguchi T., Qin L., Shimomura T., Kondo J., Matsumoto K., Denda K., Kitamura N. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:1997;27558-27564.
20. Takayama H., LaRochelle W. J., Sharp R., Otsuka T., Kriebel P., Anver M., Aaronson S. A., Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA. 94:1997;701-706.
21. Skeel A., Yoshimura T., Showalter S. D., Tanaka S., Appella E., Leonard E. J. Macrophage stimulating protein: Purification, partial amino acid sequence, and cellular activity. J. Exp. Med. 173:1991;1227-1234.
22. Gaudino G., Follenzi A., Naldini L., Collesi C., Santoro M., Gallo K. A., Godowski P. J., Comoglio P. M. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13:1994;3524-3532.
23. Medico E., Mongiovi A. M., Huff J., Jelinek M. A., Follenzi A., Gaudino G., Parsons J. T., Comoglio P. M. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell. 7:1996;495-504.
24. Santoro M. M., Collesi C., Grisendi S., Gaudino G., Comoglio P. M. Constitutive activation of the RON gene promotes invasive growth but not transformation. Mol. Cell Biol. 16:1996;7072-7083.
25. Wang M. H., Dlugosz A. A., Sun Y., Suda T., Skeel A., Leonard E. J. Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp. Cell Res. 226:1996;39-46.
26. Yoshimura T., Yuhki N., Wang M. H., Skeel A., Leonard E. J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 268:1993;15461-15468.
27. Wang M. H., Yoshimura T., Skeel A., Leonard E. J. Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade. J. Biol. Chem. 269:1994;3436-3440.
28. Wang M. H., Julian F. M., Breathnach R., Godowski P. J., Takehara T., Yoshikawa W., Hagiya M., Leonard E. J. Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain. J. Biol. Chem. 272:1997;16999-17004.
29. Waltz S. E., McDowell S. A., Muraoka R. S., Air E. L., Flick L. M., Chen Y. Q., Wang M. H., Degen S. J. Functional characterization of domains contained in hepatocyte growth factor-like protein. J. Biol. Chem. 272:1997;30526-30537.
30. Han S., Stuart L. A., Degen S. J. Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry. 30:1991;9768-9780.
31. Han S., Degen S. J. Genomic organization, chromosomal localization and developmental expression of hepatocyte growth factor-like protein. EXS. 65:1993;81-105.
32. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:1995;699-702.
33. Uehara Y., Minowa O., Mori C., Shiota K., Kuno J., Noda T., Kitamura N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702-705.
34. Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature. 376:1995;768-771.
35. Woolf A. S., Kolatsi-Joannou M., Hardman P., Andermarcher E., Moorby C., Fine L. G., Jat P. S., Noble M. D., Gherardi E. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol. 128:1995;171-184.
36. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K. M., Birchmeier C., Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131:1995;215-226.
37. Ohmichi H., Koshimizu U., Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development. Development. 125:1998;1315-1324.
38. Michalopoulos G. K., Defrances M. C. Liver regeneration. Science. 276:1997;60-66.
39. Kawaida K., Matsumoto K., Shimazu H., Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA. 91:1994;4357-4361.
40. Yanagita K., Matsumoto K., Sekiguchi K., Ishibashi H., Niho Y., Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268:1993;21212-21217.
41. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:1992;629-641.
42. Grano M., Galimi F., Zambonin G., Colucci S., Cottone E., Zallone A. Z., Comoglio P. M. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc. Natl. Acad. Sci. USA. 93:1996;7644-7648.
43. Takebayashi T., Iwamoto M., Jikko A., Matsumura T., Enomoto-Iwamoto M., Myoukai F., Koyama E., Yamaai T., Matsumoto K., Nakamura T. Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes. J. Cell Biol. 129:1995;1411-1419.
44. Galimi F., Bagnara G. P., Bonsi L., Cottone E., Follenzi A., Simeone A., Comoglio P. M. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J. Cell Biol. 127:1994;1743-1754.
45. Weimar I. S., Miranda N., Muller E. J., Hekman A., Kerst J. M., de Gast G. C., Gerritsen W. R. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp. Hematol. 26:1998;885-894.
46. Maina F., Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci. 2:1999;213-217.
47. Gaudino G., Avantaggiato V., Follenzi A., Acampora D., Simeone A., Comoglio P. M. The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene. 11:1995;2627-2637.
48. Thery C., Sharpe M. J., Batley S. J., Stern C. D., Gherardi E. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev. Genet. 17:1995;90-101.
49. Nakamura T., Aoki S., Takahashi T., Matsumoto K., Kiyohara T. Cloning and expression of Xenopus HGF-like protein (HLP) and Ron/HLP receptor implicate their involvement in early neural development. Biochem. Biophys. Res. Commun. 224:1996;564-573.
50. Muraoka R. S., Sun W. Y., Colbert M. C., Waltz S. E., Witte D. P., Degen J. L., Friezner D. S. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. J. Clin. Invest. 103:1999;1277-1285.
51. Bezerra J. A., Carrick T. L., Degen J. L., Witte D., Degen S. F. Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. J. Clin. Invest. 101:1998;1175-1183.
52. Kurihara N., Iwama A., Tatsumi J., Ikeda K., Suda T. Macrophage-stimulating protein activates STK receptor tyrosine kinase on osteoclasts and facilitates bone resorption by osteoclast-like cells. Blood. 87:1996;3704-3710.
53. Banu N., Price D. J., London R., Deng B., Mark M., Godowski P. J., Avraham H. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J. Immunol. 156:1996;2933-2940.
54. Yu H. H., Kolodkin A. L. Semaphorin signaling: A little less per-plexin. Neuron. 22:1999;11-14.
55. Mark M. D., Lohrum M., Puschel A. W. Patterning neuronal connections by chemorepulsion: The semaphorins. Cell Tissue Res. 290:1997;299-306.
56. Maestrini E., Tamagnone L., Longati P., Cremona O., Gulisano M., Bione S., Tamanini F., Neel B. G., Toniolo D., Comoglio P. M. A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. Proc. Natl. Acad. Sci. USA. 93:1996;674-678.
57. Cell. 97:1999;551-552.
58. Tessier-Lavigne M., Goodman C. S. The molecular biology of axon guidance. Science. 274:1996;1123-1133.
59. Adams R. H., Lohrum M., Klostermann A., Betz H., Puschel A. W. The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 16:1997;6077-6086.
60. Klostermann A., Lohrum M., Adams R. H., Puschel A. W. The chemorepulsive activity of the axonal guidance signal semaphorin D requires dimerization. J. Biol. Chem. 273:1998;7326-7331.
61. Yu H. H., Araj H. H., Ralls S. A., Kolodkin A. L. The transmembrane semaphorin Sema I is required in Drosophila for embryonic motor and CNS axon guidance. Neuron. 20:1998;207-220.
62. Wong J. T., Yu W. T., O'Connor T. P. Transmembrane grasshopper semaphorin I promotes axon outgrowth in vivo. Development. 124:1997;3597-3607.
63. Bagnard D., Lohrum M., Uziel D., Schel A. W., Bolz J. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development. 125:1998;5043-5053.
64. Song H., Ming G., He Z., Lehmann M., Tessier-Lavigne M., Poo M. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science. 281:1998;1515-1518.
65. Tamagnone L., Artigiani S., Chen H., He Z., Ming G. L., Song H.-J., Cheodotal A., Winberg M. L., Goodman C. S., Poo M. M., Tessier-Lavigne M., Comoglio P. M. Plexins are a large family of receptors for transmembrane, secreted and GPI-anchored semphorins in vertebrates. Cell. 99:1999;1-20.
66. Behar O., Golden J. A., Mashimo H., Schoen F. J., Fishman M. C. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 383:1996;525-528.
67. Hall K. T., Boumsell L., Schultze J. L., Boussiotis V. A., Dorfman D. M., Cardoso A. A., Bensussan A., Nadler L. M., Freeman G. J. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;11780-11785.
68. Miao H. Q., Soker S., Feiner L., Alonso J. L., Raper J. A., Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility. Functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146:1999;233-242.
69. Christensen C. R., Klingelhofer J., Tarabykina S., Hulgaard E. F., Kramerov D., Lukanidin E. Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res. 58:1998;1238-1244.
70. Yamada T., Endo R., Gotoh M., Hirohashi S. Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc. Natl. Acad. Sci. USA. 94:1997;14713-14718.
71. Bottaro D. P., Rubin J. S., Faletto D. L., Chan A. M., Kmiecik T. E., Vande W. G., Aaronson S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
72. Naldini L., Weidner K. M., Vigna E., Gaudino G., Bardelli A., Ponzetto C., Narsimhan R. P., Hartmann G., Zarnegar R., Michalopoulos G. K. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10:1991;2867-2878.
73. Wang M. H., Ronsin C., Gesnel M. C., Coupey L., Skeel A., Leonard E. J., Breathnach . Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science. 266:1994;117-119.
74. Huff J. L., Jelinek M. A., Borgman C. A., Lansing T. J., Parsons J. T. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc. Natl. Acad. Sci. USA. 90:1993;6140-6144.
75. Cooper C. S., Park M., Blair D. G., Tainsky M. A., Huebner K., Croce C. M., Vande W. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:1984;29-33.
76. Park M., Dean M., Kaul K., Braun M. J., Gonda M. A., Vande W. G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA. 84:1987;6379-6383.
77. Ronsin C., Muscatelli F., Mattei M. G., Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene. 8:1993;1195-1202.
78. Giordano S., Di Renzo M. F., Ferracini R., Chiado-Piat L., Comoglio P. M. p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. Mol. Cell. Biol. 8:1988;3510-3517.
79. Giordano S., Ponzetto C., Di Renzo M. F., Cooper C. S., Comoglio P. M. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature. 339:1989;155-156.
80. Giordano S., Di Renzo M. F., Narsimhan R. P., Cooper C. S., Rosa C., Comoglio P. M. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene. 4:1989;1383-1388.
81. Crepaldi T., Prat M., Giordano S., Medico E., Comoglio P. M. Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J. Biol. Chem. 269:1994;1750-1755.
82. Winberg M. L., Noordermeer J. N., Tamagnone L., Comoglio P. M., Spriggs M. K., Tessier-Lavigne M., Goodman C. S. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell. 95:1998;903-916.
83. Ferracini R., Longati P., Naldini L., Vigna E., Comoglio P. M. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J. Biol. Chem. 266:1991;19558-19564.
84. Longati P., Bardelli A., Ponzetto C., Naldini L., Comoglio P. M. Tyrosines 1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene. 9:1994;49-57.
85. Naldini L., Vigna E., Ferracini R., Longati P., Gandino L., Prat M., Comoglio P. M. The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation. Mol. Cell. Biol. 11:1991;1793-1803.
86. Gandino L., Di Renzo M. F., Giordano S., Bussolino F., Comoglio P. M. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein. Oncogene. 5:1990;721-725.
87. Gandino L., Longati P., Medico E., Prat M., Comoglio P. M. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269:1994;1815-1820.
88. Bardelli A., Longati P., Gramaglia D., Stella M. C., Comoglio P. M. Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene. 15:1997;3103-3111.
89. Boccaccio C., Ando M., Tamagnone L., Bardelli A., Michieli P., Battistini C., Comoglio P. M. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature. 391:1998;285-288.
90. Graziani A., Gramaglia D., Cantley L. C., Comoglio P. M. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J. Biol. Chem. 266:1991;22087-22090.
91. Graziani A., Gramaglia D., Dalla Z. P., Comoglio P. M. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. J. Biol. Chem. 268:1993;9165-9168.
92. Iwama A., Yamaguchi N., Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 15:1996;5866-5875.
93. Nguyen L., Holgado-Madruga M., Maroun C., Fixman E. D., Kamikura D., Fournier T., Charest A., Tremblay M. L., Wong A. J., Park M. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J. Biol. Chem. 272:1997;20811-20819.
94. Pelicci G., Giordano S., Zhen Z., Salcini A. E., Lanfrancone L., Bardelli A., Panayotou G., Waterfield M. D., Ponzetto C., Pelicci P. G. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene. 10:1995;1631-1638.
95. Ponzetto C., Bardelli A., Maina F., Longati P., Panayotou G., Dhand R., Waterfield M. D., Comoglio P. M. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol. 13:1993;4600-4608.
96. Ponzetto C., Bardelli A., Zhen Z., Maina F., Dalla Z. P., Giordano S., Graziani A., Panayotou G., Comoglio P. M. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 77:1994;261-271.
97. Villa-Moruzzi E., Lapi S., Prat M., Gaudino G., Comoglio P. M. A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J. Biol. Chem. 268:1993;18176-18180.
98. Weidner K. M., Di Cesare S., Sachs M., Brinkmann V., Behrens J., Birchmeier W. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature. 384:1996;173-176.
99. Maina F., Casagranda F., Audero E., Simeone A., Comoglio P. M., Klein R., Ponzetto C. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell. 87:1996;531-542.
100. Kameyama T., Murakami Y., Suto F., Kawakami A., Takagi S., Hirata T., Fujisawa H. Identification of plexin family molecules in mice. Biochem. Biophys. Res. Commun. 226:1996;396-402.
101. Ohta K., Mizutani A., Kawakami A., Murakami Y., Kasuya Y., Takagi S., Tanaka H., Fujisawa H. Plexin: A novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions. Neuron. 14:1995;1189-1199.
102. Kolodkin A. L., Matthes D. J., Goodman C. S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell. 75:1993;1389-1399.
103. Sandoval I. V., Bakke O. Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol. 4:1994;292-297.
104. Comeau M. R., Johnson R., DuBose R. F., Petersen M., Gearing P., VandenBos T., Park L., Farrah T., Buller R. M., Cohen J. I., Strockbine L. D., Rauch C., Spriggs M. K. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity. 8:1998;473-482.
105. Chen H., He Z., Bagri A., Tessier-Lavigne M. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron. 21:1998;1283-1290.
106. He Z., Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell. 90:1997;739-751.
107. Kolodkin A. L., Levengood D. V., Rowe E. G., Tai Y. T., Giger R. J., Ginty D. D. Neuropilin is a semaphorin III receptor. Cell. 90:1997;753-762.
108. Nakamura F., Tanaka M., Takahashi T., Kalb R. G., Strittmatter S. M. Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron. 21:1998;1093-1100.
109. Bardelli A., Longati P., Gramaglia D., Basilico C., Tamagnone L., Giordano S., Ballinari D., Michieli P., Comoglio P. M. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl. Acad. Sci. USA. 95:1998;14379-14383.
110. Giordano S., Bardelli A., Zhen Z., Menard S., Ponzetto C., Comoglio P. M. A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc. Natl. Acad. Sci. USA. 94:1997;13868-13872.
111. Ponzetto C., Zhen Z., Audero E., Maina F., Bardelli A., Basile M. L., Giordano S., Narsimhan R., Comoglio P. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility. J. Biol. Chem. 271:1996;14119-14123.
112. Hartmann G., Weidner K. M., Schwarz H., Birchmeier W. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem. 269:1994;21936-21939.
113. Ridley A. J., Comoglio P. M., Hall A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15:1995;1110-1122.
114. Potempa S., Ridley A. J. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell. 9:1998;2185-2200.
115. Tanimura S., Chatani Y., Hoshino R., Sato M., Watanabe S., Kataoka T., Nakamura T., Kohno M. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering. Oncogene. 17:1998;57-65.
116. McCawley L. J., Li S., Wattenberg E. V., Hudson L. G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274:1999;4347-4353.
117. Simon C., Juarez J., Nicolson G. L., Boyd D. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res. 56:1996;5369-5374.
118. Royal I., Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270:1995;27780-27787.
119. Bardelli A., Basile M. L., Audero E., Giordano S., Wennstrom S., Menard S., Comoglio P. M., Ponzetto C. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis. Oncogene. 18:1999;1139-1146.
120. Sander E. E., van Delft S., ten Klooster J. P., Reid T., van der Kammen R. A., Michiels F., Collard J. G. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143:1998;1385-1398.
121. Khwaja A., Lehmann K., Marte B. M., Downward J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273:1998;18793-18801.
122. Park W. S., Dong S. M., Kim S. Y., Na E. Y., Shin M. S., Pi J. H., Kim B. J., Bae J. H., Hong Y. K., Lee K. S., Lee S. H., Yoo N. J., Jang J. J., Pack S., Zhuang Z., Schmidt L., Zbar B., Lee J. Y. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res. 59:1999;307-310.
123. Schmidt L., Duh F. M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S. W., Zhuang Z., Lubensky I., Dean M., Allikmets R., Chidambaram A., Bergerheim U. R., Feltis J. T., Casadevall C., Zamarron A., Bernues M., Richard S., Lips C. J., Walther M. M., Tsui L. C., Geil L., Orcutt M. L., Stackhouse T., Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:1997;68-73.
124. Jeffers M., Schmidt L., Nakaigawa N., Webb C. P., Weirich G., Kishida T., Zbar B., Vande W. G. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl. Acad. Sci. USA. 94:1997;11445-11450.
125. Di Renzo M. F., Olivero M., Ferro S., Prat M., Bongarzone I., Pilotti S., Belfiore A., Costantino A., Vigneri R., Pierotti M. A. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene. 7:1992;2549-2553.
126. Di Renzo M. F., Olivero M., Giacomini A., Porte H., Chastre E., Mirossay L., Nordlinger B., Bretti S., Bottardi S., Giordano S. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1:1995;147-154.
127. Ferracini R., Di Renzo M. F., Scotlandi K., Baldini N., Olivero M., Lollini P., Cremona O., Campanacci M., Comoglio P. M. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene. 10:1995;739-749.
128. Ferracini R., Olivero M., Di Renzo M. F., Martano M., De Giovanni C., Nanni P., Basso G., Scotlandi K., Lollini P. L., Comoglio P. M. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene. 12:1996;1697-1705.
129. Jeffers M., Fiscella M., Webb C. P., Anver M., Koochekpour S., Vande W. G. The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA. 95:1998;14417-14422.
130. Meiners S., Brinkmann V., Naundorf H., Birchmeier W. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene. 16:1998;9-20.
131. Rong S., Segal S., Anver M., Resau J. H., Vande W. G. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA. 91:1994;4731-4735.